Refractive outcomes of femtosecond laser-assisted secondary arcuate incisions in patients with residual refractive astigmatism after trifocal intraocular lens implantations.


Journal

Journal of cataract and refractive surgery
ISSN: 1873-4502
Titre abrégé: J Cataract Refract Surg
Pays: United States
ID NLM: 8604171

Informations de publication

Date de publication:
01 2019
Historique:
received: 13 09 2017
revised: 06 08 2018
accepted: 09 08 2018
pubmed: 21 11 2018
medline: 9 11 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

To evaluate the refractive and visual outcomes of arcuate incisions performed with the femtosecond laser in patients with a residual refractive astigmatism after refractive lens exchange (RLE) with trifocal intraocular lenses (IOLs). EuroEyes Clinical Group, Hamburg, Germany. Retrospective interventional case series. Pseudophakic patients with remaining refractive astigmatism after RLE with a trifocal IOL were treated with femtosecond laser-assisted corneal arcuate incisions. Patients who had a previous corneal treatment were excluded. Outcome measures were uncorrected (UDVA) and corrected distance visual acuities, manifest refraction, and a power vector analysis. The study enrolled 95 eyes of 70 patients. The mean follow-up was 5.6 months ± 4.9 (SD). Constructing an astigmatic power vector (APV) with Jackson cross-cylinder axes at 180 degrees and 90 degrees and Jackson cross-cylinder axes at 45 degrees and 135 degrees, the mean preoperative vector length was 0.46 ± 0.16 diopter (D). The mean postoperative APV was 0.17 ± 0.16 D. This difference was statistically significant (P < .001). The difference between the UDVA preoperatively (0.17 ± 0.15) and postoperatively (0.08 ± 0.10) was statistically significant (P < .001). No intraoperative or postoperative complications were observed. Femtosecond laser-assisted corneal arcuate incisions were safe, efficient, and feasible to reduce refractive astigmatism after trifocal IOL implantation.

Identifiants

pubmed: 30454903
pii: S0886-3350(18)30790-9
doi: 10.1016/j.jcrs.2018.08.024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-34

Informations de copyright

Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Auteurs

Inger Lüdeke (I)

EuroEyes Clinical Group, Hamburg, Germany. Electronic address: luedeke@euroeyes.de.

Johannes Gonnermann (J)

EuroEyes Clinical Group, Hamburg, Germany; Charité Universitätsmedizin Berlin, Munich, Germany.

Jørn Jørgensen (J)

EuroEyes Clinical Group, Hamburg, Germany.

Thomas Neuhann (T)

EuroEyes Clinical Group, Hamburg, Germany; Department of Ophthalmology, Berlin, MVZ Prof. Neuhann, Munich, Germany.

Keith McKay (K)

EuroEyes Clinical Group, Hamburg, Germany.

Mathias Fleischer (M)

EuroEyes Clinical Group, Hamburg, Germany.

Peter Galambos (P)

EuroEyes Clinical Group, Hamburg, Germany.

Ralf-Christian Lerche (RC)

EuroEyes Clinical Group, Hamburg, Germany; Universitätsklinikum Hamburg-Eppendorf, Department of Ophthalmology, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH